Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Crinetics Pharmaceuticals (CRNX) Return on Assets (2018 - 2025)

Historic Return on Assets for Crinetics Pharmaceuticals (CRNX) over the last 8 years, with Q3 2025 value amounting to 0.34%.

  • Crinetics Pharmaceuticals' Return on Assets fell 500.0% to 0.34% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.34%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.29% for FY2024, which is 1400.0% up from last year.
  • According to the latest figures from Q3 2025, Crinetics Pharmaceuticals' Return on Assets is 0.34%, which was down 500.0% from 0.28% recorded in Q2 2025.
  • In the past 5 years, Crinetics Pharmaceuticals' Return on Assets ranged from a high of 0.23% in Q1 2025 and a low of 0.61% during Q2 2023
  • Its 5-year average for Return on Assets is 0.35%, with a median of 0.33% in 2021.
  • Per our database at Business Quant, Crinetics Pharmaceuticals' Return on Assets plummeted by -2600bps in 2023 and then soared by 3400bps in 2024.
  • Crinetics Pharmaceuticals' Return on Assets (Quarter) stood at 0.29% in 2021, then crashed by -53bps to 0.44% in 2022, then increased by 26bps to 0.33% in 2023, then increased by 23bps to 0.25% in 2024, then tumbled by -36bps to 0.34% in 2025.
  • Its Return on Assets was 0.34% in Q3 2025, compared to 0.28% in Q2 2025 and 0.23% in Q1 2025.